ANI Pharmaceuticals Inc
ANIP
$78.85+3.56%
End of day · as of Sep 22, 2026, 1:00 AM ET
Mkt cap
$1.41B
EV/Sales
1.63
P/E ratio
N/A
FY2025 Revenue
$883.37M
EPS (TTM)
$4.59
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
8.87%
Beta
0.55
Div yield
N/A
Sector
Healthcare
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ANIP revenue for 2025-12-31 was $883.4M. Net income was $78.3M. Revenue was up 43.8% from 2024-12-31 to 2025-12-31. ANIP currently screens at market cap $1.41B.
Use this ANIP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ANIP income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
ANI Pharmaceuticals Inc (ANIP) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached ANI Pharmaceuticals Inc (ANIP) revenue for Dec 31, 2025 was $883.4M. Net income was $78.3M. Statements: https://lician.com/financials/anip
ANI Pharmaceuticals Inc (ANIP) market capitalization is $1.41B on the latest cached snapshot.
ANI Pharmaceuticals Inc (ANIP) cached previous close $76.14; day range $75.00 – $79.43; volume 561,714. Session quote: https://lician.com/quote/anip
ANI Pharmaceuticals Inc (ANIP) latest cached earnings event is "ANIP earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ANIP filing is 8-K · Aug 24, 2026. Filings: https://lician.com/sec/anip